BioAge Labs Price to Free Cash Flow Ratio 1971-1970 | BIOA

BioAge Labs price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as

BioAge Labs Price to Free Cash Flow Ratio 1971-1970 | BIOA

BioAge Labs price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$174.4B
Vertex Pharmaceuticals (VRTX)$125.1B
Regeneron Pharmaceuticals (REGN)$111.8B
Bristol Myers Squibb (BMY)$106.8B
Gilead Sciences (GILD)$105.9B
CSL (CSLLY)$97.5B
GSK (GSK)$81.1B
Alnylam Pharmaceuticals (ALNY)$36.4B
Argenex SE (ARGX)$32.5B
BioNTech SE (BNTX)$28.6B
Biogen (BIIB)$27.9B
Illumina (ILMN)$23.7B
Moderna (MRNA)$22.2B
BeiGene (BGNE)$22.1B
Genmab (GMAB)$15.7B
BioMarin Pharmaceutical (BMRN)$13.3B
Exact Sciences (EXAS)$13.1B
Insmed (INSM)$12.9B
Vaxcyte (PCVX)$12.6B
Incyte (INCY)$12.6B
Sarepta Therapeutics (SRPT)$11.9B
Bio-Techne Corp (TECH)$11.7B
QIAGEN (QGEN)$10.1B
Bio-Rad Laboratories (BIO.B)$9.3B
Legend Biotech (LEGN)$9.1B
Roivant Sciences (ROIV)$8.8B
Revolution Medicines (RVMD)$8.2B
Repligen (RGEN)$8B
Intra-Cellular Therapies (ITCI)$7.8B
Ascendis Pharma (ASND)$7.8B